I am an Associate Scientist and Team Leader at King Faisal Specialist Hospital and Research Centre (KFSHRC), Riyadh, with over 15 years of experience in translational cancer research, molecular oncology, and preclinical therapeutics. I completed my postdoctoral training in toxicology and cancer biology at the University of Kentucky, USA, after earning a PhD in Immunology from Mahatma Gandhi University, India. My research bridges fundamental cancer biology with clinically relevant applications, focusing on molecular signaling, epigenetics, the tumor microenvironment, cancer heterogeneity, and therapy resistance. I aim to identify and validate biomarkers and therapeutic targets for improved cancer diagnosis, prognosis, and personalized treatment, while developing robust preclinical models to evaluate new therapies. I have authored more than 60 peer-reviewed publications, received over 4,200 citations, and achieved an H-index of 35. I have also presented more than 25 abstracts at international conferences and served as Guest Editor for special journal issues. Through multidisciplinary leadership and service on the Animal Care and Use Committee, I remain committed to innovative, collaborative, and ethically responsible research that translates scientific discoveries into better patient outcomes.
I am an Associate Scientist and Team Leader at King Faisal Specialist Hospital and Research Centre (KFSHRC), Riyadh, with over 15 years of experience in translational cancer research, molecular oncology, and preclinical therapeutics. I completed my postdoctoral training in toxicology and cancer biology at the University of Kentucky, USA, after earning a PhD in Immunology from Mahatma Gandhi University, India. My research bridges fundamental cancer biology with clinically relevant applications, focusing on molecular signaling, epigenetics, the tumor microenvironment, cancer heterogeneity, and therapy resistance. I aim to identify and validate biomarkers and therapeutic targets for improved cancer diagnosis, prognosis, and personalized treatment, while developing robust preclinical models to evaluate new therapies. I have authored more than 60 peer-reviewed publications, received over 4,200 citations, and achieved an H-index of 35. I have also presented more than 25 abstracts at international conferences and served as Guest Editor for special journal issues. Through multidisciplinary leadership and service on the Animal Care and Use Committee, I remain committed to innovative, collaborative, and ethically responsible research that translates scientific discoveries into better patient outcomes.